234 related articles for article (PubMed ID: 30236178)
1. How can integrated care and research assist in achieving the SDG targets for diabetes, tuberculosis and HIV/AIDS?
Harries AD; Lin Y; Kumar AMV; Satyanarayana S; Zachariah R; Dlodlo RA
Int J Tuberc Lung Dis; 2018 Oct; 22(10):1117-1126. PubMed ID: 30236178
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
Semu M; Fenta TG; Medhin G; Assefa D
BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
[TBL] [Abstract][Full Text] [Related]
3. Improving tuberculosis screening and isoniazid preventive therapy in an HIV clinic in Addis Ababa, Ethiopia.
Zaeh S; Kempker R; Stenehjem E; Blumberg HM; Temesgen O; Ofotokun I; Tenna A
Int J Tuberc Lung Dis; 2013 Nov; 17(11):1396-401. PubMed ID: 24125440
[TBL] [Abstract][Full Text] [Related]
4. New vaccines for the prevention of tuberculosis in human immunodeficiency virus infection.
von Reyn CF; Bakari M; Arbeit RD; Lahey T; Ramadhani A; Egwaga S
Int J Tuberc Lung Dis; 2012 Jun; 16(6):718-23. PubMed ID: 22507085
[TBL] [Abstract][Full Text] [Related]
5. Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries.
Charles MK; Lindegren ML; Wester CW; Blevins M; Sterling TR; Dung NT; Dusingize JC; Avit-Edi D; Durier N; Castelnuovo B; Nakigozi G; Cortes CP; Ballif M; Fenner L;
PLoS One; 2016; 11(4):e0153243. PubMed ID: 27073928
[TBL] [Abstract][Full Text] [Related]
6. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of tuberculosis and HIV: recent advances in understanding and responses.
Martinson NA; Hoffmann CJ; Chaisson RE
Proc Am Thorac Soc; 2011 Jun; 8(3):288-93. PubMed ID: 21653530
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the intensified tuberculosis case finding guidelines for children living with HIV.
Sawry S; Moultrie H; Van Rie A
Int J Tuberc Lung Dis; 2018 Nov; 22(11):1322-1328. PubMed ID: 30355412
[TBL] [Abstract][Full Text] [Related]
9. Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues.
Aït-Khaled N; Alarcon E; Bissell K; Boillot F; Caminero JA; Chiang CY; Clevenbergh P; Dlodlo R; Enarson DA; Enarson P; Ferroussier O; Fujiwara PI; Harries AD; Heldal E; Hinderaker SG; Kim SJ; Lienhardt C; Rieder HL; Rusen ID; Trébucq A; Van Deun A; Wilson N
Int J Tuberc Lung Dis; 2009 Aug; 13(8):927-35. PubMed ID: 19723371
[TBL] [Abstract][Full Text] [Related]
10. Community-based multi-disease prevention campaigns for controlling human immunodeficiency virus-associated tuberculosis.
Suthar AB; Klinkenberg E; Ramsay A; Garg N; Bennett R; Towle M; Sitienei J; Smyth C; Daniels C; Baggaley R; Gunneberg C; Williams B; Getahun H; van Gorkom J; Granich RM
Int J Tuberc Lung Dis; 2012 Apr; 16(4):430-6. PubMed ID: 22640510
[TBL] [Abstract][Full Text] [Related]
11. Addressing diabetes mellitus as part of the strategy for ending TB.
Harries AD; Kumar AM; Satyanarayana S; Lin Y; Zachariah R; Lönnroth K; Kapur A
Trans R Soc Trop Med Hyg; 2016 Mar; 110(3):173-9. PubMed ID: 26884497
[TBL] [Abstract][Full Text] [Related]
12. Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS.
Gutierrez EB; Gomes V; Picone CM; Suga H; Atomiya AN
HIV Med; 2009 Oct; 10(9):564-72. PubMed ID: 19785665
[TBL] [Abstract][Full Text] [Related]
13. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.
Shayo GA; Chitama D; Moshiro C; Aboud S; Bakari M; Mugusi F
BMC Public Health; 2017 Jul; 18(1):35. PubMed ID: 28724374
[TBL] [Abstract][Full Text] [Related]
15. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
[TBL] [Abstract][Full Text] [Related]
16. Implementation of isoniazid preventive therapy in people living with HIV in Zambia: challenges and lessons.
Kagujje M; Mubiana ML; Mwamba E; Muyoyeta M
BMC Public Health; 2019 Oct; 19(1):1329. PubMed ID: 31640657
[TBL] [Abstract][Full Text] [Related]
17. Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries.
Harries AD; Schwoebel V; Monedero-Recuero I; Aung TK; Chadha S; Chiang CY; Conradie F; Dongo JP; Heldal E; Jensen P; Nyengele JPK; Koura KG; Kumar AMV; Lin Y; Mlilo N; Nakanwagi-Mukwaya A; Ncube RT; Nyinoburyo R; Oo NL; Patel LN; Piubello A; Rusen ID; Sanda T; Satyanarayana S; Syed I; Thu AS; Tonsing J; Trébucq A; Zamora V; Zishiri C; Hinderaker SG; Aït-Khaled N; Roggi A; Caminero Luna J; Graham SM; Dlodlo RA; Fujiwara PI
Int J Tuberc Lung Dis; 2019 Feb; 23(2):241-251. PubMed ID: 30808459
[TBL] [Abstract][Full Text] [Related]
18. Review of policy and status of implementation of collaborative HIV-TB activities in 23 high-burden countries.
Gupta S; Granich R; Date A; Lepere P; Hersh B; Gouws E; Samb B
Int J Tuberc Lung Dis; 2014 Oct; 18(10):1149-58. PubMed ID: 25216827
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis screening and isoniazid preventive therapy implementation: a Brazilian experience.
Swaminathan S; Chandrasekaran P
Expert Rev Anti Infect Ther; 2014 Mar; 12(3):289-92. PubMed ID: 24455973
[TBL] [Abstract][Full Text] [Related]
20. Assessing the impact of antiretroviral therapy on tuberculosis notification rates among people with HIV: a descriptive analysis of 23 countries in sub-Saharan Africa, 2010-2015.
Surie D; Borgdorff MW; Cain KP; Click ES; DeCock KM; Yuen CM
BMC Infect Dis; 2018 Sep; 18(1):481. PubMed ID: 30257667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
